This week, there are 12 drugs in the patent and exclusivity list. They are: - VIIV HEALTHCARE CO's RUKOBIA, containing active ingredient FOSTEMSAVIR TROMETHAMINE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STIOLTO RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's SPIRIVA RESPIMAT, containing active ingredient TIOTROPIUM BROMIDE - VIFOR PHARMA INC's VELTASSA, containing active ingredient PATIROMER SORBITEX CALCIUM - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - TEVA PHARMACEUTICAL INDUSTRIES LTD's AIRDUO RESPICLICK, containing active ingredient FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - PF PRISM CV's XALKORI, containing active ingredient CRIZOTINIB - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's JARDIANCE, containing active ingredient EMPAGLIFLOZIN Read More

This week, there are 7 drugs in the patent and exclusivity list. They are: - DURYSTA by AbbVie Inc, containing active ingredient Bimatoprost - IXEMPRA KIT by R-Pharm US LLC, containing active ingredient Ixabepilone - XIFAXAN by Salix Pharmaceuticals Inc, containing active ingredient Rifaximin - DIFFERIN by Galderma Laboratories LP, containing active ingredient Adapalene - NEXLIZET by Esperion Therapeutics Inc, containing active ingredient Bempedoic Acid; Ezetimibe ​- NEXLETOL by Esperion Therapeutics Inc, containing active ingredient Bempedoic Acid - XARELTO by Janssen Pharmaceuticals Inc, containing active ingredient Rivaroxaban Read More

This week, there are 6 drugs in the patent and exclusivity list. They are: - Tudorza Pressair by Covis Pharma GMBH, containing active ingredient Aclidinium Bromide - Duaklir Pressair by Covis Pharma GMBH, containing active ingredient Aclidinium Bromide and Formoterol Fumarate - Scenesse by Clinuvel Inc, containing active ingredient Afamelanotide - Hysingla ER by Purdue Pharma LP, containing active ingredient Hydrocodone Bitartrate - Izervay by Astellas Pharma US Inc, containing active ingredient Avacincaptad Pegol Sodium - Symdeko by Vertex Pharmaceuticals Inc, containing active ingredient Ivacaftor and Tezacaftor Read More

The topic of this report is a long-acting HIV "vaccine" called Lenacapavir, developed by Gilead Sciences in the United States. Read More

We, Unibest, are excited to share with you the remarkable benefits and opportunities that Reteplase brings to the global market. Read More

Unibest is proud to partner with a renowned Chinese Pharmaceutical company and announce the following global licensing opportunities:1. Read More

Thrombolytic drugs play a crucial role in treating various venous and arterial thromboembolic conditions, particularly acute myocardial infarction. Read More

This week, there are 4 drugs in the patent and exclusivity list. They are: - BRISTOL MYERS SQUIBB CO's SPRYCEL, containing active ingredient DASATINIB - AMERICAN REGENT INC's INJECTAFER, containing active ingredient FERRIC CARBOXYMALTOSE - ABBVIE INC's KYBELLA, containing active ingredient DEOXYCHOLIC ACID - MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC's ZOLINZA, containing active ingredient VORINOSTAT Read More

This week, there are 10 drugs in the patent and exclusivity list. They are: - Myfembree by Sumitomo Pharma Switzerland, containing active ingredient Estradiol, Norethindrone Acetate, and Relugolix - Orgovyx by Sumitomo Pharma Switzerland, containing active ingredient Relugolix - Nulibry by Sentynl Therapeutics, containing active ingredient Fosdenopterin Hydrobromide - Delstrigo by Merck Sharp and Dohme, containing active ingredient Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate - Pifeltro by Merck Sharp and Dohme, containing active ingredient Doravirine - Geodon by Viatris Specialty, containing active ingredient Ziprasidone Hydrochloride - Reyvow by Eli Lilly, containing active ingredient Lasmiditan Succinate - Cabenuva Kit by ViiV Healthcare, containing active ingredient Cabotegravir and Rilpivirine - Vocabria by ViiV Healthcare, containing active ingredient Cabotegravir Sodium - Imbruvica by Pharmacyclics, containing active ingredient Ibrutinib Read More